BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 538672)

  • 1. In vivo measurement of platelet activity in postoperative patients.
    Stulberg BN; Weksler BB; Ranawat CS
    Surg Forum; 1979; 30():489-91. PubMed ID: 538672
    [No Abstract]   [Full Text] [Related]  

  • 2. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neonatal platelet: evaluation of platelet malonyl dialdehyde formation as an indicator of prostaglandin synthesis.
    Stuart MJ
    Br J Haematol; 1978 May; 39(1):83-90. PubMed ID: 666980
    [No Abstract]   [Full Text] [Related]  

  • 4. Malondialdehyde production by platelets during secondary aggregation.
    MacFarlane DE; Gardner S; Lipson C; Mills DC
    Thromb Haemost; 1977 Dec; 38(4):1002-9. PubMed ID: 579680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activity (malondialdehyde production) after orthopaedic surgery: the effect of aspirin.
    Stulberg BN; Dorr LD; Ranawat CS; Weksler BB; Schneider R
    J Bone Joint Surg Am; 1981 Feb; 63(2):288-94. PubMed ID: 7462284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
    Best LC; Jones PB; Russell RG
    Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the inhibitory effects of aspirin and ticlopidine on platelet aggregation and Ca2+ mobilization in rat platelets.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):275-8. PubMed ID: 3024274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation, malondialdehyde generation and production time in children with sickle cell anaemia.
    Buchanan GR; Holtkamp CA
    Thromb Haemost; 1981 Dec; 46(4):690-3. PubMed ID: 7330819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine inhibits the synthesis of malondialdehyde by human platelets in vitro.
    Martin JF; Greaves M
    Cancer; 1982 Feb; 49(4):665-8. PubMed ID: 6799184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of hydralazine on the formation of malondialdehyde in platelet-rich plasma and aortic rings in the rat].
    Cano E; Orallo F; Cadavid I
    Arch Farmacol Toxicol; 1986 Apr; 12(1):49-55. PubMed ID: 3090953
    [No Abstract]   [Full Text] [Related]  

  • 13. [A basic study on malondialdehyde estimation as an indicator of prostaglandin production by human platelets (author's transl)].
    Endo Y; Sato M; Mamiya S; Takahashi K
    Rinsho Byori; 1979 Oct; 27(10):939-42. PubMed ID: 533917
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
    Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
    Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome.
    Stuart MJ; Spitzer RE; Coppe D
    Pediatrics; 1983 Jan; 71(1):120-4. PubMed ID: 6336835
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of SAS 650 (Furofenac) on malondialydehyde production by platelets.
    Corbelli GP; Stanzani L; Mastacchi R; Barbanti M; Montecchi L
    Agents Actions; 1984 Jun; 14(5-6):735-7. PubMed ID: 6475669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay.
    Nenci GG; Parise P; Capodicasa E; Berrettini M
    Haemostasis; 1983; 13(1):53-60. PubMed ID: 6404715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
    Pönicke K; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a biochemical method for measuring platelet life-span.
    Stoltz JF; Voisin P
    Cell Biol Int Rep; 1979 Aug; 3(5):441-5. PubMed ID: 487454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.